Inhibikase Therapeutics (IKT) Return on Equity [ROE] (2020 - 2026)
Inhibikase Therapeutics (IKT) posted Return on Equity [ROE] of -40.78% for Q2 2026, up 12.53 percentage points from -53.31% a year earlier but down 8.35 percentage points from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Inhibikase Therapeutics' Return on Equity [ROE] came in at -38.82%, up 15.20 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a four-year change of +22.53 percentage points (FY2021 to FY2025).
- In prior years, Inhibikase Therapeutics' Return on Equity [ROE] was -54.02% in FY2024 (+71.49 pp), -125.51% in FY2023 (-64.52 pp), -60.99% in FY2022 (+0.37 pp) and -61.35% in FY2021.
- Quarterly Return on Equity [ROE] has run from a low of -878.83% in Q3 2024 to a high of -24.28% in Q3 2021 over five years.
- On a year-over-year basis, Return on Equity [ROE] has increased in each of the last seven quarters, with an average year-over-year change of +79.44 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2025, with a gain of 811.98 percentage points; the weakest was Q3 2024, with a drop of 762.71 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -32.43% (Q1 2026), -42.29% (Q4 2025) and -66.85% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Inhibikase Therapeutics | 281.11 Mn | -420.36 Mn | - | -11,479,904.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -11,479,904.39% |
| Jun 30, 2026 | -12,237,297.52% |
| Mar 31, 2026 | -5,824,871.44% |
| Dec 31, 2025 | -8,069,535.00% |
| Sep 30, 2025 | -12,968,171.52% |
| Jun 30, 2025 | -11,964,375.61% |
| Mar 31, 2025 | -5,491,635.97% |
| Dec 31, 2024 | -10,513,210.12% |
| Sep 30, 2024 | -217,204,713.76% |
| Jun 30, 2024 | -83,529,354.48% |
| Mar 31, 2024 | -218.18% |
| Dec 31, 2023 | -147.20% |
| Sep 30, 2023 | -111.11% |
| Jun 30, 2023 | -85.06% |
| Mar 31, 2023 | -76.53% |
| Dec 31, 2022 | -77.75% |
| Sep 30, 2022 | -68.78% |
| Jun 30, 2022 | -59.18% |
| Mar 31, 2022 | -46.36% |
| Dec 31, 2021 | -36.25% |
API Access
Inhibikase Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();